B-cell-independent sialylation of IgG

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 26, 2016, Pages 7207-7212

  Jones, Mark B ^a   Oswald, Douglas M ^a   Joshi, Smita ^b   Whiteheart, Sidney W ^b   Orlando, Ron ^c,d   Cobb, Brian A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

^d NONE   (United States)

Author keywords

B cell; IgG; IVIg; Sialylation; Sialyltransferase

Indexed keywords

IMMUNOGLOBULIN G; SIALYLTRANSFERASE; SIALYLTRANSFERASE ST6GAL1; UNCLASSIFIED DRUG; BETA-D-GALACTOSIDE ALPHA 2-6-SIALYLTRANSFERASE; OVALBUMIN; POLYSACCHARIDE; SIALIC ACID DERIVATIVE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY SECRETING CELL; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CENTRAL VEIN; COMPARATIVE STUDY; CONTROLLED STUDY; DEGRANULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SECRETORY CELL; SIALYLATION; THROMBOCYTE; THROMBOCYTE COUNT; ANIMAL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER; METABOLISM; PROTEIN PROCESSING;

ANIMALS; B-LYMPHOCYTES; BLOOD PLATELETS; IMMUNOGLOBULIN G; LIVER; MICE, KNOCKOUT; OVALBUMIN; POLYSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIALIC ACIDS; SIALYLTRANSFERASES;

EID: 84976578131     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1523968113     Document Type: Article

References (37)

1. Dwyer JM (1992) Manipulating the immune system with immune globulin. N Engl J Med 326(2):107-116.
2. Kaneko Y, Nimmerjahn F, Ravetch JV (2006) Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313(5787):670-673.
3. Anthony RM, Wermeling F, Karlsson MC, Ravetch JV (2008) Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Natl Acad Sci USA 105(50):19571-19578.
4. Anthony RM, Kobayashi T, Wermeling F, Ravetch JV (2011) Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature 475(7354): 110-113.
5. Wang TT, et al. (2015) Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy. Cell 162(1):160-169.
6. Anthony RM, et al. (2008) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320(5874):373-376.
7. Espy C, et al. (2011) Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's). Arthritis Rheum 63(7):2105-2115.
8. van de Geijn FE, et al. (2009) Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: Results from a large prospective cohort study. Arthritis Res Ther 11(6):R193.
9. Martin LT, Marth JD, Varki A, Varki NM (2002) Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation. J Biol Chem 277(36):32930-32938.
10. Barb AW, Brady EK, Prestegard JH (2009) Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I. Biochemistry 48(41):9705-9707.
11. Hennet T, Chui D, Paulson JC, Marth JD (1998) Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA 95(8):4504-4509.
12. Lehoux S, et al. (2010) Transcriptional regulation of the human ST6GAL2 gene in cerebral cortex and neuronal cells. Glycoconj J 27(1):99-114.
13. Jones MB, et al. (2010) Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis. J Biol Chem 285(32):25009-25017.
14. Jones MB, Nasirikenari M, Lugade AA, Thanavala Y, Lau JT (2012) Anti-inflammatory IgG production requires functional P1 promoter in β-galactoside α2,6-sialyltransferase 1 (ST6Gal-1) gene. J Biol Chem 287(19):15365-15370.
15. Rickert RC, Roes J, Rajewsky K (1997) B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 25(6):1317-1318.
16. Collins BE, Smith BA, Bengtson P, Paulson JC (2006) Ablation of CD22 in ligand-deficient mice restores B cell receptor signaling. Nat Immunol 7(2):199-206.
17. Kaplan HA, Woloski BM, Hellman M, Jamieson JC (1983) Studies on the effect of inflammation on rat liver and serum sialyltransferase. Evidence that inflammation causes release of Gal beta 1 leads to 4GlcNAc alpha 2 leads to 6 sialyltransferase from liver. J Biol Chem 258(19):11505-11509.
18. Colley KJ, Lee EU, Adler B, Browne JK, Paulson JC (1989) Conversion of a Golgi apparatus sialyltransferase to a secretory protein by replacement of the NH2-terminal signal anchor with a signal peptide. J Biol Chem 264(30):17619-17622.
19. Weinstein J, Lee EU, McEntee K, Lai PH, Paulson JC (1987) Primary structure of betagalactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor. JBiolChem262(36): 17735-17743.
20. Schauer R (1978) Characterization of sialic acids. Methods Enzymol 50:64-89.
21. Varki A, Diaz S (1984) The release and purification of sialic acids from glycoconjugates: Methods to minimize the loss and migration of O-acetyl groups. Anal Biochem 137(1):236-247.
22. Wandall HH, et al. (2012) The origin and function of platelet glycosyltransferases. Blood 120(3):626-635.
23. Colli W (1993) Trans-sialidase: A unique enzyme activity discovered in the protozoan Trypanosoma cruzi. FASEB J 7(13):1257-1264.
24. Wu ZL, Ethen CM, Prather B, Machacek M, Jiang W (2011) Universal phosphatasecoupled glycosyltransferase assay. Glycobiology 21(6):727-733.
25. Lee MM, et al. (2014) Platelets support extracellular sialylation by supplying the sugar donor substrate. J Biol Chem 289(13):8742-8748.
26. Ye S, et al. (2014) Platelet secretion and hemostasis require syntaxin-binding protein STXBP5. J Clin Invest 124(10):4517-4528.
27. Karsten CM, et al. (2012) Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med 18(19): 1401-1406.
28. Ackerman ME, et al. (2013) Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2b. J Virol 87(10):5468-5476.
29. Ackerman ME, et al. (2013) Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest 123(5):2183-2192.
30. Shields RL, et al. (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J Biol Chem 277(30):26733-26740.
31. Mizushima T, et al. (2011) Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes Cells 16(11):1071-1080.
32. Ferwerda W, Blok CM, Heijlman J (1981) Turnover of free sialic acid, CMP-sialic acid, and bound sialic acid in rat brain. J Neurochem 36(4):1492-1499.
33. Meng L, et al. (2013) Enzymatic basis for N-glycan sialylation: Structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation. JBiolChem288(48):34680-34698.
34. Varki A, Gagneux P (2012) Multifarious roles of sialic acids in immunity. Ann N Y Acad Sci 1253:16-36.
35. Macauley MS, et al. (2013) Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis. J Clin Invest 123(7):3074-3083.
36. Toscano MA, et al. (2007) Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8(8):825-834.
37. Tao S, Huang Y, Boyes BE, Orlando R (2014) Liquid chromatography-selected reaction monitoring (LC-SRM) approach for the separation and quantitation of sialylated N-glycans linkage isomers. Anal Chem 86(21):10584-10590.